Novel Oral Treatment Reduced Liver Fat in MASH

(MedPage Today) — WASHINGTON — Daily treatment with the investigational oral agent HU6 reduced liver fat and body weight without muscle loss in patients with metabolic dysfunction-associated steatohepatitis (MASH), according to the phase IIa…